CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,191,320
- in 3 filings, $2.1M under 10b5-1 plans
Net −$2,191,320. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −6,479 | $16.32 | $106K | 232,940 |
| 2025-07-24 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −7,123 | $17.31 | $123K | 239,419 |
| 2025-06-26 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −9,838 | $18.40 | $181K | 246,542 |
| 2025-02-26 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −5,280 | $15.78 | $83K | 256,380 |
| 2025-02-19 | Tade Brad L. CFO and Treasurer | Grant or award | +62,227 | 261,660 | ||
| 2025-02-19 | Tade Brad L. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +93,023 | 93,023 | ||
| 2024-11-22 | Tade Brad L. CFO and Treasurer | Sale | −15,000 | $21.15 | $317K | 199,433 |
| 2024-07-24 | Tade Brad L. CFO and Treasurer | Grant or award | +72,400 | 214,433 | ||
| 2024-07-24 | Tade Brad L. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +115,100 | 115,100 |
Page 1 of 1 · 9 trades